Gregory Asciolla, Co-Chair of the Firm's Antitrust and Competition Litigation Practice, focuses on representing businesses and public pension funds in complex antitrust and commodities class actions. Currently, Greg represents clients in global antitrust matters involving alleged price-fixing, benchmark and commodities manipulation, pay-for-delay, and other anticompetitive practices.
Greg began his career as an attorney at the U.S. Department of Justice's Antitrust Division, where he focused on anticompetitive conduct in the healthcare industry.
Greg is a member of the New York State Bar Association's Antitrust Law Section, and currently serves as co-chairman of the antitrust and trade regulations committee of the New York County Lawyers' Association.
Greg's recent publications include "FDA Risk-Evaluation Guidance Unlikely to Help Generics" in Law360, and "Protecting Patents Through Tribal Sovereign Immunity: A Failed Experiment" in Antitrust Advisor.
In 2018, Greg led the pro bono litigation team that secured asylum for a young Ugandan man persecuted in his home country for being gay.